Inflammation and scarring of mucous membranes, particularly in the eyes and mouth, are the symptoms of cicatricial pemphigoid, also known as mucous membrane pemphigoid. In this article, we'll explore this condition's causes, symptoms, diagnosis, treatment, and prevention measures.
Despite not knowing the exact cause of cicatricial pemphigoid, it is believed to involve an abnormal immune response that attacks the mucous membranes of the body. As a result of the immune system mistakenly attacking proteins that are essential for maintaining the integrity of mucous membranes in patients with cicatricial pemphigoid, inflammation, blistering, and scarring occur.
The symptoms of cicatricial pemphigoid may vary depending on the affected area, but commonly include:
A painful blister, erosion, or ulcer in the mouth, tongue, gums, or throat may indicate oral involvement
There may be redness, irritation, or burning sensation in the eyes (conjunctivitis), scarring of the conjunctiva, corneal abrasions, or loss of vision in the eyes.
Involvement of the nasal cavity: Congestion, discharge, or crusting of the nasal cavity
Blisters or erosions in the genital area are signs of genital involvement
Medical history, physical examination, and laboratory tests are typically used to diagnose cicatricial pemphigoid. Diagnostic tests may include:
A biopsy is an examination under a microscope of a small sample of affected tissue, such as mucous membranes or skin, for signs of inflammation, blistering, or scarring.
Tests of direct immunofluorescence (DIF) are performed under a microscope using fluorescent dyes to detect antibodies and complement proteins along the basement membrane of the affected tissue, which are characteristic of pemphigoid disorders.
Tests for indirect immunofluorescence (IIF) can confirm the diagnosis of scarring pemphigoid by detecting antibodies against components of the basement membrane in blood serum.
Cicatricial pemphigoid is treated by controlling inflammation, relieving symptoms, and preventing scarring and complications.
The application of corticosteroid creams or ointments to affected areas can reduce inflammation and promote healing.
Corticosteroids: Oral corticosteroids may be prescribed in cases of severe or widespread disease to suppress the immune response and control inflammation.
As steroid-sparing agents or adjunctive therapies, immunomodulatory drugs such as methotrexate, azathioprine, or mycophenolate mofetil can be used to reduce steroid doses and side effects.
In individuals with ocular involvement, lubricating eye drops or ointments may relieve dryness and discomfort.
To restore tissue integrity and function, surgical procedures such as amniotic membrane transplantation or mucous membrane grafting may be considered in cases of severe scarring.
It may not always be possible to prevent cicatricial pemphigoid, which is primarily autoimmune in nature, but early diagnosis and prompt treatment can reduce scarring and complications. To manage symptoms and prevent long-term damage to mucous membranes, individuals with cicatricial pemphigoid should work closely with a dermatologist, ophthalmologist, or other healthcare professional.
In conclusion, cicatricial pemphigoid is a rare autoimmune disorder characterized by chronic inflammation and scarring of mucous membranes, particularly in the eyes and mouth. A proper diagnosis, treatment, and management of this condition is vital to improving outcomes and quality of life. A healthcare professional should be consulted if you experience symptoms of cicatricial pemphigoid, such as oral or ocular discomfort.
